Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05035056 · ClinicalTrials.gov registry record

WARRIOR Ancillary Study for CCTA Analysis

A clinical trial of Coronary Artery Disease and Ischemia, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
191
Enrollment target
1
Study location

NCT05035056 is a study of Coronary Artery Disease and Ischemia that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 191 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05035056, a study of Coronary Artery Disease and Ischemia, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
191 participants
Enrollment target
1
Study location

Study Summary

In this study, quantitative characterization of plaque using coronary computed tomographic angiography (CTA) will be used to determine if women who were treated with intensive medical therapy have a greater reduction in the amount and type of cholesterol plaque compared to women receiving usual care and if this results in beneficial changes in clinical symptoms. The study will provide an understanding of how intensive medical therapy works in providing clinical benefit in women with nonobstructive plaque.

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 191 participants
Start Date 2020-07-01
Est. Completion 2026-01-31

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT05035056

The ClinicalTrials.gov registry entry for NCT05035056 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (85% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT05035056 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05035056 about?

NCT05035056 is a clinical study titled "WARRIOR Ancillary Study for CCTA Analysis". In this study, quantitative characterization of plaque using coronary computed tomographic angiography (CTA) will be used to determine if women who were treated with intensive medical therapy have a greater reduction in the amount and type of cholesterol plaque compared to women receiving usual care...

What is the current status of trial NCT05035056?

This trial is currently completed. The enrollment target is 191 participants. The study started on 2020-07-01. Estimated completion is 2026-01-31.

What conditions does trial NCT05035056 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Ischemia, Non-Obstructive Coronary Atherosclerosis.

Who is sponsoring clinical trial NCT05035056?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05035056 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.